Predictors of Physical Activity in Adult Patients With Hemophilic Arthropathy
NCT ID: NCT06960499
Last Updated: 2025-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
88 participants
OBSERVATIONAL
2025-05-04
2025-06-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives. i) To assess the level of physical activity in patients with hemophilia; ii) To identify the best predictive model for physical activity in adult patients with hemophilic arthropathy.
Material and method. Multicenter cross-sectional cohort study. Eighty-eight patients will be recruited. The dependent variable will be physical activity (International Physical Activity Questionnaire). Secondary variables will be kinesiophobia (Tampa Kinesiophobia Scale), functionality (Functional Independence Scale in Hemophilia), pain intensity, and clinical, anthropometric, and sociodemographic variables.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain in Patients With Congenital Coagulopathies
NCT03499522
Foot Core Exercise Training with Telerehabilitation
NCT06667856
Exercise and Respiratory Therapy in Patients With Rheumatoid Arthritis / Collagenosis and Pulmonary Hypertension
NCT00491309
Increasing Physical Activity in Older Adults With Osteoarthritis Pain: Examining a Brief Behavioral Intervention
NCT04490395
MST in Patients With Inflammatory Rheumatic Disease
NCT04998955
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observacional group
Patients with hemophilia A or B, of legal age, with a medical diagnosis of severe phenotype of the disease and hemophilic arthropathy in the lower limbs.
Surveys
No intervention will be carried out in this study; the recruited patients will only complete the questionnaires provided below
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surveys
No intervention will be carried out in this study; the recruited patients will only complete the questionnaires provided below
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Over the age of majority
* With a medical diagnosis of severe phenotype of the disease
* With a medical diagnosis of hemophilic arthropathy in the lower limbs
* Under on-demand or prophylactic drug treatment.
Exclusion Criteria
* Patients who are dependent for activities of daily living
* Patients over the age of 60
* Patients with cognitive impairments that prevent them from understanding the questionnaires
18 Years
65 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Católica San Antonio de Murcia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rubén Cuesta-Barriuso, PhD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rubén Cuesta-Barriuso
Role: PRINCIPAL_INVESTIGATOR
Universidad de Oviedo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad Católica San Antonio de Murcia
Murcia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HeActivity
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.